Could renal impairment be a positive predictor of outcome in autografts for myeloma?
- PMID: 27183097
- DOI: 10.1038/bmt.2016.138
Could renal impairment be a positive predictor of outcome in autografts for myeloma?
Comment on
-
Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival.Bone Marrow Transplant. 2016 Oct;51(10):1337-1341. doi: 10.1038/bmt.2016.136. Epub 2016 May 16. Bone Marrow Transplant. 2016. PMID: 27183094
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical